Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Post-transcriptional regulation of stem and progenitor cell function

Award Number: R35GM156830
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/20/2025
PERIOD OF PERFORMANCE END DATE: 12/31/2029

Group Awards By:

View Award Description

Post-transcriptional regulation of stem and progenitor cell function - ABSTRACT The genome is transmitted from one generation to the next by two highly specialized cell types, sperm and egg. In the adult testis, spermatogonial stem cells continuously produce progenitors that rapidly expand their population (transit-amplify) before undergoing terminal differentiation into sperm. Across tissues, cell state transitions from stem cell to progenitor to differentiated cell require regulated gene expression programs. Post- transcriptional mechanisms that regulate RNA, from splicing through translation, play a major role in shaping these gene expression programs. My research program seeks to define how post-transcriptional regulation shapes gene expression programs to support the function of spermatogonial stem and progenitor cells, using mouse as our model. We leverage single cell methods as well as approaches unique to spermatogenesis to provide enhanced stage-specific insights into progenitor function. We will focus on two Areas: Area 1: During spermatogenesis, retinoic acid (RA) signaling induces early progenitors to form committed progenitors via canonical regulation of transcription and noncanonical regulation of translation. We have demonstrated that RNA-binding protein and translational regulator DAZL supports the formation of committed progenitors, but whether DAZL’s activity affects RA-induced molecular changes remains unclear. Here, we will test the hypothesis that DAZL enhances RA-mediated changes in transcription and translation to induce formation of committed progenitors. Area 2: Committed spermatogonial progenitors enter terminal differentiation when they initiate meiosis in response to RA signaling. RA activates gene expression of Stra8 and Meiosin, which encode a heterodimeric transcription factor that drives the initiation of meiosis. We recently discovered that the RA-dependent upregulation of Meiosin gene expression requires the RNA-binding complex MEIOC-YTHDC2-RBM46, which mediates mRNA degradation of transcriptional repressors of Meiosin. Based on these data, we proposed the conceptually novel model that committed progenitors must acquire the molecular competence to initiate meiosis in response to RA. Furthermore, this competence is regulated by MEIOC-YTHDC2-RBM46 destabilizing mRNA. Here, we propose to expand on this model. We will define the mechanism by which MEIOC-YTHDC2-RBM46-bound mRNAs are degraded, identify MEIOC’s molecular function within the complex, and determine whether genetic ablation of transcriptional repressors targeted by MEIOC-YTHDC2- RBM46 is sufficient to rescue the competence of Meioc knockout committed progenitors. Our proposed research directions will define how post-transcriptional regulation interacts with transcriptional networks to support spermatogonial stem and progenitor cell function, with implications for human reproductive health. More broadly, our studies will inform how post-transcriptional mechanisms may be implemented in other contexts of normal cellular differentiation and co-opted in cancer.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $401,250 )
2026	2026	CHILDRENS HOSPITAL MEDICAL CENTER	3333 BURNET AVE	CINCINNATI	OH	45229	HAMILTON	USA	Biomedical Research and Research Training	001	2	3/11/2026	NON-COMPETING CONTINUATION	$40,125
2026	2026	CHILDRENS HOSPITAL MEDICAL CENTER	3333 BURNET AVE	CINCINNATI	OH	45229	HAMILTON	USA	Biomedical Research and Research Training	000	2	12/11/2025	NON-COMPETING CONTINUATION	$361,125
														Subtotal = $401,250

Issue Date FY: 2025 ( Subtotal = $380,546 )
2025	2025	CHILDRENS HOSPITAL MEDICAL CENTER	3333 BURNET AVE	CINCINNATI	OH	45229	HAMILTON	USA	Biomedical Research and Research Training	000	1	1/20/2025	NEW	$380,546
														Subtotal = $380,546

Grand Total All Awards = $781,796

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Post-transcriptional regulation of stem and progenitor cell function

Award Number: R35GM156830

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/20/2025

PERIOD OF PERFORMANCE END DATE: 12/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer